Stay updated on Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for the completed pediatric baricitinib atopic dermatitis study is displayed, with its study details, results measures, participation criteria, and supporting documents.SummaryDifference100%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the usual study-record content, indicating an access restriction or outage rather than an update to the study data.SummaryDifference21%

Stay in the know with updates to Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.